Free Trial

Vsee Health (VSEE) Competitors

Vsee Health logo
$1.22 +0.01 (+0.41%)
Closing price 03:45 PM Eastern
Extended Trading
$1.22 0.00 (0.00%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

VSEE vs. MRAI, MGRX, BRTX, KDLY, SSY, OTRK, BGLC, ACON, ATIP, and DHAC

Should you be buying Vsee Health stock or one of its competitors? The main competitors of Vsee Health include Marpai (MRAI), Mangoceuticals (MGRX), BioRestorative Therapies (BRTX), Kindly MD (KDLY), SunLink Health Systems (SSY), Ontrak (OTRK), BioNexus Gene Lab (BGLC), Aclarion (ACON), ATI Physical Therapy (ATIP), and Digital Health Acquisition (DHAC). These companies are all part of the "healthcare" industry.

Vsee Health vs.

Marpai (NASDAQ:MRAI) and Vsee Health (NASDAQ:VSEE) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, community ranking, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

Marpai and Vsee Health both received 2 outperform votes by MarketBeat users. However, 100.00% of users gave Vsee Health an outperform vote while only 66.67% of users gave Marpai an outperform vote.

CompanyUnderperformOutperform
MarpaiOutperform Votes
2
66.67%
Underperform Votes
1
33.33%
Vsee HealthOutperform Votes
2
100.00%
Underperform Votes
No Votes

Vsee Health has a consensus target price of $5.00, suggesting a potential upside of 311.52%. Given Vsee Health's stronger consensus rating and higher possible upside, analysts clearly believe Vsee Health is more favorable than Marpai.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Marpai
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Vsee Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

Vsee Health has a net margin of 0.00% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat Vsee Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Marpai-85.70% N/A -100.23%
Vsee Health N/A -182.59%-58.26%

Vsee Health has lower revenue, but higher earnings than Marpai.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Marpai$34.87M0.45-$28.75M-$2.07-0.51
Vsee Health$6.38M0.69-$4.41MN/AN/A

In the previous week, Vsee Health's average media sentiment score of 1.89 beat Marpai's score of 0.00 indicating that Vsee Health is being referred to more favorably in the news media.

Company Overall Sentiment
Marpai Neutral
Vsee Health Very Positive

49.8% of Marpai shares are owned by institutional investors. Comparatively, 1.0% of Vsee Health shares are owned by institutional investors. 61.3% of Marpai shares are owned by insiders. Comparatively, 6.6% of Vsee Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Vsee Health beats Marpai on 9 of the 13 factors compared between the two stocks.

Get Vsee Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for VSEE and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VSEE vs. The Competition

MetricVsee HealthHealth services IndustryComputer SectorNASDAQ Exchange
Market Cap$4.38M$852.11M$23.83B$8.04B
Dividend YieldN/A2.55%2.96%4.22%
P/E RatioN/A53.9542.7818.83
Price / Sales0.697.392,007.34106.72
Price / CashN/A26.1434.7734.62
Price / Book-0.364.026.314.33
Net Income-$4.41M-$5.50M$736.77M$247.97M
7 Day Performance-4.33%-0.77%2.71%2.71%
1 Month Performance1.25%3.86%2.95%3.37%
1 Year PerformanceN/A22.02%52,746.70%5.80%

Vsee Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VSEE
Vsee Health
1.9246 of 5 stars
$1.22
+0.4%
$5.00
+311.5%
N/A$4.38M$6.38M0.00N/APositive News
MRAI
Marpai
N/A$1.01
-3.8%
N/A-50.2%$15.05M$34.87M-0.38150Upcoming Earnings
MGRX
Mangoceuticals
0.918 of 5 stars
$2.49
-3.1%
N/A-97.3%$12.87M$615,873.00-0.433Short Interest ↓
BRTX
BioRestorative Therapies
3.9929 of 5 stars
$1.71
-2.3%
$18.00
+952.6%
+29.9%$12.83M$401,000.00-1.127Short Interest ↓
KDLY
Kindly MD
1.2786 of 5 stars
$1.47
-16.0%
N/AN/A$8.86M$2.72M-2.23N/AShort Interest ↓
Positive News
SSY
SunLink Health Systems
N/A$0.94
+3.5%
N/A+60.5%$6.60M$31.23M6.701,376
OTRK
Ontrak
3.2771 of 5 stars
$1.44
+2.1%
$45.00
+3,025.0%
-63.8%$6.07M$10.85M-0.14250
BGLC
BioNexus Gene Lab
0.2676 of 5 stars
$2.67
-2.2%
N/A-54.6%$4.80M$9.26M0.0030News Coverage
Gap Down
ACON
Aclarion
1.5132 of 5 stars
$7.93
-11.7%
$11,758.50
+148,178.7%
-99.7%$4.62M$45,724.000.007Positive News
Gap Down
ATIP
ATI Physical Therapy
N/A$1.00
+17.6%
N/A-80.0%$4.41M$741.86M-0.055,600Upcoming Earnings
Gap Up
DHAC
Digital Health Acquisition
N/A$1.19
+3.7%
N/A-89.7%$4.30MN/A0.002,021

Related Companies and Tools


This page (NASDAQ:VSEE) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners